Dr. Bernard Stephen Lebenson, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2212 Upper Valley Ct, Cary, NC 27518 Phone: 919-851-0888 Fax: 919-851-9992 |
Dr. Brandon S Rubens, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 218 Ashville Ave, Cary, NC 27518 Phone: 919-576-2330 Fax: 919-854-7842 |
Dr. Kevin P Perry, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
Dr. Marc D Benevides, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 160 Macgregor Pines Dr, Suite 205, Cary, NC 27511 Phone: 919-851-5482 Fax: 919-859-1729 |
Dr. Jordan Thomas Brady, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
Paige Hamilton, MD Urology Medicare: Medicare Enrolled Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
Dr. William Steel Kizer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
Kevin Paul Khoudary, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
Frank Louis Tortora Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 110 Kildaire Park Dr Ste 500, Cary, NC 27518 Phone: 919-467-3203 |
News Archive
A study led by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Colorectal cancer is the cancer of the large intestine (colon and rectum) and is the most common cancer in Singapore.
Thirty eight year old French woman Isabelle Dinoire who received the world's first face transplant has made a remarkable recovery and is now able to go out without anyone noticing her scars.
Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.
Capital Impact Partners announced today that it provided nearly $27.5 million in financing to projects delivering social impact for underserved communities across the U.S. during the second quarter of 2015. These projects are expected to increase access to health care services, dignified aging options, healthy food, and education for low-income people in seven states, while also creating nearly 250 jobs.
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their severity throughout the course of a patient's treatment.
› Verified 4 days ago